- Role of ruxolitinib in the treatment of primary myelofibrosis2015 | Faculty of Medicine in Hradec Králové
- Experience with ruxolitinib in the treatment of myelofibrosis and polycythaemia vera at Czech haematological institutions2017 | Faculty of Medicine in Hradec Králové
- Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone2016 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Complete Regression of Bone Marrow Fibrosis Following Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Idiopathic Myelofibrosis2004 | First Faculty of Medicine
- New onset of myelofibrosis in association with pulmonary arterial hypertension2005 | First Faculty of Medicine
- New onset of myelofibrosis in association with pulmonary arterial hypertension2005 | Faculty of Physical Education and Sport
- Impact of immunomodulatory drugs in treatment of primary myelofibrosis2015 | Faculty of Medicine in Hradec Králové
- High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertension2006 | First Faculty of Medicine
- High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertension2006 | Faculty of Physical Education and Sport
- New approaches in the diagnosis and the treatment of idiopathic myelofibrosisPublication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CINC424A2401Publication without faculty affiliation
- Idiopatic myelofibrosis complicated by portal hypertension treated with transjugular intrahepatic portosystemic shunt (TIPS)Publication without faculty affiliation
- Idiopathic myelofibrosis complicated by portal hypertension treated with a transjugular intrahepatic portosystemic shunt TIPS2001 | Publication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: GS-US-352-0101Publication without faculty affiliation
- Allogenic transplantation of haematopoietic stem cells in idiopathic myelofibrosisPublication without faculty affiliation
- Rare congenital chromosomal aberration dic(X;Y)(p22.33;p11.32) in a patient with primary myelofibrosis2016 | First Faculty of Medicine, Central Library of Charles University
- Successful treatment of anemia and trombocytopenia with Thalidomide and Prednison in idiopatic myelofibrosis2006 | Publication without faculty affiliation
- Decrease of myelofibrosis after therapy 2-CdA in patients with hairy cell leukemiaPublication without faculty affiliation
- Case 2-2012: a 57-year-old woman with post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for primary myelofibrosis2012 | Faculty of Medicine in Hradec Králové
- Allogenic transplantation of haemoplastic progenitor cells in chronic myeloproliferations2006 | Publication without faculty affiliation
- Allogenic transplantation of haemoplastic progenitor cells in chronic myeloproliferations2006 | First Faculty of Medicine
- The constitutive mobilization of bone marrow - repopulating cells into the peripheral blood in idiopathic myelofibrosis2005 | First Faculty of Medicine
- The constitutive mobilization of bone marrow - repopulating cells into the peripheral blood in idiopathic myelofibrosis2005 | Faculty of Physical Education and Sport
- Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases2005 | First Faculty of Medicine
- Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases2005 | Faculty of Physical Education and Sport
- Complete Regression of Bone Marrow Fibrosis Following Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Idiopathic Myelofibrosis2004 | Faculty of Medicine in Hradec Králové
- Allogeneic hematopoietic stem -cell transplantation with reduced-intensity conditioning in intermediate - or high-risk patients with myelofibrosis with myeloid metaplasia2005 | First Faculty of Medicine
- Allogeneic hematopoietic stem -cell transplantation with reduced-intensity conditioning in intermediate - or high-risk patients with myelofibrosis with myeloid metaplasia2005 | Faculty of Physical Education and Sport
- Analysis of risk factors: The rationale of the guidelines of the Czech Hematological Society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia2006 | Second Faculty of Medicine
- Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview2011 | Second Faculty of Medicine